Agreement Between Standard and Continuous Wireless Vital Sign Measurements
NCT ID: NCT05325814
Last Updated: 2022-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2019-12-18
2020-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This validation study, which is part of the WARD-SX project, aimed to assess the agreement between vital signs recorded by standard and novel wireless devices
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wireless Assessment of Respiratory and Circulatory Distress in Vascular Surgical Patients - An Observational Study
NCT04628858
Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery
NCT04257344
Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward
NCT07105189
Postoperative Opioid and Respiratory Depression in Opioid Naive and Chronic Opioid Patients
NCT06227208
Registry Construction of Intraoperative Vital Signs and Clinical Information in Surgical Patients
NCT02914444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The chance to enhance monitoring has arisen with recent technological advances in the form of small wearable and wireless devices that continuously record vital signs. Wearable devices enable continuous monitoring outside the intensive care unit and post-anesthesia care unit, thus enabling early detection of patient deterioration. However, before implementing such devices in hospital settings, good accuracy, and precision of measurements is required.
This validation study, which is part of the WARD-SX project, aimed to assess the agreement between vital signs recorded by standard and novel wireless devices
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device: Continuous monitoring system
Continuous monitoring system Recruited patients will be continuously monitored with Isansys Lifetouch patch, Nonin WristOx 3150, Isansys wireless blood pressure monitor (Meditech Blue BP-05) and standard monitoring at the post anesthesia care unit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Estimated surgical intervention duration ≥2 hours.
Exclusion Criteria
60 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Camilla Haahr-Raunkjaer
MD.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eske K Aasvang, Dr. Med
Role: STUDY_CHAIR
Rigshospitalet, Denmark
Camilla Haahr-Raunkjaer, MD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology, Center for Cancer and Organ Diseases
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WARD_SX_validation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.